We know what’s coming and we are prepared.
Europe is crippled by two fears that kill massive company creation.
Fear of failure and fear of success.
America turned failure into a badge of honor, a “near-pornographic” obsession with it as proof you’re swinging big.
Europe does the opposite on both counts.
Failure carries shame, and wild success is culturally toxic in social democracies.
Founders building something enormous quickly feel pressure to cash out early rather than dominate.
And the result is plenty of competent mid-sized firms. Almost zero world changing outliers.
No European Google. No Amazon. No Microsoft.
America’s edge has been the reverse, tolerating and rewarding big success while treating failure as data, not disgrace.
That combination built the most dynamic entrepreneurship ecosystem on Earth.
But the European disease is spreading here.
Socialist policies and “eat the rich” culture taking over big cities with punitive taxes on success, regulatory moats, and open disdain for winners are breeding the same risk aversion and envy.
Ambition gets short-circuited and scaling becomes politically risky.
The entrepreneurship ecosystem shrinks. Founders hesitate on moonshots. Capital and talent flow to freer places. Quick exits replace empire building.
And society loses the most. The outlier companies that never get built won’t create millions of jobs, new industries, and transformative progress that raises living standards for everyone.
Wealth that isn’t created can’t be redistributed.
Europe chose envy and security over ambition and dynamism and it’s paying for it in technological lag.
America doesn’t have to, unless we let the same mindset take root in our own cities.
🄳🄾🄾🄼🄿🤖🅂🅃🄸🄽🄶
Here is the TRUTH: Dangerous gain-of-function research was funded by the U.S. government around the world, directed and approved by people like Dr Fauci. @DNIGabbard exposed that yesterday.
Using U.S. government data, put together and uncovered by career subject matter experts in the Intelligence Community and other government agencies, yesterday’s release highlighted one example of the many overseas biolabs funded by the U.S., the research conducted there, and the significant risks they pose to the world, especially when located in a country at war.
